Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: A case report

Journal of Medical Case Reports

Volumn 9, Issue 1, 2015, Pages

  Frech, Tracy M ^a   Revelo, Monica P ^a   Ryan, John J ^a   Shah, Ami A ^b   Gordon, Jessica ^c   Domsic, Robyn ^d   Hant, Faye ^e   Assassi, Shervin ^f   Shanmugam, Victoria K ^g   Hinchcliff, Monique ^h   Steen, Virginia ⁱ   Khanna, Dinesh ^j   Bernstein, Elana J ^k   Cox, James ^a   Luem, Nick ^a   Drakos, Stavros ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ GEORGETOWN UNIVERSITY   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k Georgetown University ^*  (United States)

more..

Author keywords

Autopsy; Metabolomics; Scleroderma; Systemic sclerosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHOTREXATE; MYCOPHENOLATE MOFETIL; PHOSPHODIESTERASE V INHIBITOR;

ACUTE HEART FAILURE; ADULT; ANEMIA; ARGON PLASMA COAGULATION; ARTICLE; AUTOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; DIURESIS; DYSPNEA; ECHOCARDIOGRAPHY; FATIGUE; FEMALE; FINGER ULCER; HEART CATHETERIZATION; HEART DEATH; HEART DILATATION; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY DISEASE; LEG EDEMA; LUNG FUNCTION TEST; METABOLOMICS; MIDDLE AGED; NAUSEA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCLERODERMA RENAL CRISIS; SKIN TIGHTNESS; SLEEP DISORDERED BREATHING; STOMACH ANTRUM VASCULAR ECTASIA; SYSTEMIC SCLEROSIS; ULCER HEALING; VASODILATATION; WEAKNESS; COMPLICATION; DIFFUSE SCLERODERMA; FATALITY; HEART MUSCLE; METABOLISM; PATHOLOGY;

AUTOPSY; DYSPNEA; FATAL OUTCOME; FEMALE; HUMANS; HYPERTENSION, PULMONARY; METABOLOMICS; MIDDLE AGED; MYOCARDIUM; SCLERODERMA, DIFFUSE;

EID: 84935007957     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/s13256-015-0587-7     Document Type: Article

References (18)

1. Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):432-7.
2. Frech TM, Shanmugam VK, Shah AA, Assassi S, Gordon JK, Hant FN, et al. Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol. 2013;31(2 Suppl 76):166-71.
3. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009;68(5):620-8.
4. Casella M, Carbucicchio C, Russo E, Pizzamiglio F, Golia P, Conti S, et al. Electrical storm in systemic sclerosis: inside the electroanatomic substrate. World J Cardiol. 2014;6(10):1127-30.
5. Lambova S. Cardiac manifestations in systemic sclerosis. World J Cardiol. 2014;6(9):993-1005.
6. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus. 2005;14(9):702-7.
7. Kaddurah-Daouk R, Rozen S, Matson W, Han X, Hulette CM, Burke JR, et al. Metabolomic changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement. 2011;7(3):309-17.
8. Chalkias A, Fanos V, Noto A, Castren M, Gulati A, Svavarsdottir H, et al. 1H NMR-metabolomics: can they be a useful tool in our understanding of cardiac arrest? Resuscitation. 2014;85(5):595-601.
9. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455(7216):1054-6.
10. Trupp M, Zhu H, Wikoff WR, Baillie RA, Zeng ZB, Karp PD, et al. Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment. PLoS One. 2012;7(7):e38386.
11. Rogers AJ, McGeachie M, Baron RM, Gazourian L, Haspel JA, Nakahira K, et al. Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One. 2014;9(1):e87538.
12. Weaver AL, Divertie MB, Titus JL. The lung scleroderma. Mayo Clin Proc. 1967;42(11):754-66.
13. Oram S, Stokes W. The heart in scleroderma. Br Heart J. 1961;23:243-59.
14. Sharnoff JG, Carideo HL, Stein ID. Cortisone-treated scleroderma; report of a case with autopsy findings. JAMA. 1951;145(16):1230-2.
15. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9(4):311-7.
16. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum. 2007;56(11):3827-36.
17. Dinser R, Frerix M, Meier FM, Klingel K, Rolf A. Endocardial and myocardial involvement in systemic sclerosis-is there a relevant inflammatory component? Joint Bone Spine. 2013;80(3):320-3.
18. Penn H, Denton CP. Diagnosis, management and prevention of scleroderma renal disease. Curr Opin Rheumatol. 2008;20(6):692-6.